This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Follow-up and tests of cure

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • follow-up should be offered at about 2-3 weeks after commencing treatment - this is to check adherence to treatment and risk of reinfection, and for contact tracing
  • tests of cure are not routinely indicated following treatment with standard regimens, as long as partners are known to have been treated and adherence to therapy is likely
  • however, in pregnancy, tests of cure are desirable
    • due to higher positive chlamydia tests after treatment in pregnancy, attributed to either less efficacious treatment regime, non compliance or re-infection, it is recommended that pregnant woman must have a test of cure 5 weeks after completing therapy, 6 weeks later if given azithromycin.
    • doxycycline and ofloxacin are contraindicated (1)

Reference:

  1. BASHH. 2006 UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis
  2. Drug and Therapeutics Bulletin (2001), 39 (4), 27-30.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.